Advanced search

Long term follow-up of the PRIMA study : half of patients receiving rituximab maintenance remain progression free at 10 years

(2017) BLOOD. 130(suppl. 1).
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Salles, Gilles Andre, John Francis Seymour, Pierre Feugier, Fritz Offner, Armando Lopez-Guillermo, David Belada, Luc Xerri, et al. 2017. “Long Term Follow-up of the PRIMA Study : Half of Patients Receiving Rituximab Maintenance Remain Progression Free at 10 Years.” In Blood. Vol. 130.
APA
Salles, G. A., Seymour, J. F., Feugier, P., Offner, F., Lopez-Guillermo, A., Belada, D., Xerri, L., et al. (2017). Long term follow-up of the PRIMA study : half of patients receiving rituximab maintenance remain progression free at 10 years. BLOOD (Vol. 130). Presented at the 59th Annual meeting of the American Society of Hematology (ASH).
Vancouver
1.
Salles GA, Seymour JF, Feugier P, Offner F, Lopez-Guillermo A, Belada D, et al. Long term follow-up of the PRIMA study : half of patients receiving rituximab maintenance remain progression free at 10 years. BLOOD. 2017.
MLA
Salles, Gilles Andre et al. “Long Term Follow-up of the PRIMA Study : Half of Patients Receiving Rituximab Maintenance Remain Progression Free at 10 Years.” Blood. Vol. 130. 2017. Print.
@inproceedings{8593840,
  articleno    = {abstract 486},
  author       = {Salles, Gilles Andre and Seymour, John Francis and Feugier, Pierre and Offner, Fritz and Lopez-Guillermo, Armando and Belada, David and Xerri, Luc and Bouabdallah, Reda and Catalano, John and Brice, Pauline and Haioun, Corinne and Martin, Alejandro and Pedersen, Lars Moller and Delmer, Alain Jacques and Simpson, David and Leppa, Sirpa and Soubeyran, Pierre and Casasnovas, Rene-Olivier and Intragumtornchai, Tanin and Ribrag, Vincent and Silva, Maria Gomes and Nicolas-Virelizier, Emmanuelle and Lister, Thomas and Estell, Jane and Milone, Gustavo and Sonet, Anne and Assemat, Julie and Zeuner, Harald and Coiffier, Bertrand and Tilly, Herve},
  booktitle    = {BLOOD},
  issn         = {0006-4971},
  language     = {eng},
  location     = {Atlanta, GA, USA},
  number       = {suppl. 1},
  title        = {Long term follow-up of the PRIMA study : half of patients receiving rituximab maintenance remain progression free at 10 years},
  volume       = {130},
  year         = {2017},
}

Web of Science
Times cited: